The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Motion Sickness Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
The global Motion Sickness Treatment market size is expected to reach US$ 653 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Motion Sickness Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Motion Sickness Treatment market. Anticholinergic, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antihistamines segment is estimated at % CAGR for the next seven-year period.
Motion sickness is a common condition experienced by around 50% to 60% of the general global population. It is more common in children and elderly. Various prescription and over the counter (OTC) drugs and products are available for treat motion sickness.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Motion Sickness Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Motion Sickness Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Motion Sickness Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Motion Sickness Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Motion Sickness Treatment covered in this report include GlaxoSmithKline, Perrigo Company, Prestige Brands, WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals, Myungmoon Pharm, Baxter International and Reliefband Technologies, etc.
The global Motion Sickness Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Perrigo Company
Prestige Brands
WellSpring Pharmaceutical Corporation
Caleb Pharmaceuticals
Myungmoon Pharm
Baxter International
Reliefband Technologies
Global Motion Sickness Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Motion Sickness Treatment market, Segment by Type:
Anticholinergic
Antihistamines
Others
Global Motion Sickness Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Motion Sickness Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
The global Motion Sickness Treatment market size is expected to reach US$ 653 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Motion Sickness Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Motion Sickness Treatment market. Anticholinergic, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antihistamines segment is estimated at % CAGR for the next seven-year period.
Motion sickness is a common condition experienced by around 50% to 60% of the general global population. It is more common in children and elderly. Various prescription and over the counter (OTC) drugs and products are available for treat motion sickness.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Motion Sickness Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Motion Sickness Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Motion Sickness Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Motion Sickness Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Motion Sickness Treatment covered in this report include GlaxoSmithKline, Perrigo Company, Prestige Brands, WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals, Myungmoon Pharm, Baxter International and Reliefband Technologies, etc.
The global Motion Sickness Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Perrigo Company
Prestige Brands
WellSpring Pharmaceutical Corporation
Caleb Pharmaceuticals
Myungmoon Pharm
Baxter International
Reliefband Technologies
Global Motion Sickness Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Motion Sickness Treatment market, Segment by Type:
Anticholinergic
Antihistamines
Others
Global Motion Sickness Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Motion Sickness Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Motion Sickness Treatment
1.1 Motion Sickness Treatment Market Overview
1.1.1 Motion Sickness Treatment Product Scope
1.1.2 Motion Sickness Treatment Market Status and Outlook
1.2 Global Motion Sickness Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Motion Sickness Treatment Market Size by Region (2018-2029)
1.4 Global Motion Sickness Treatment Historic Market Size by Region (2018-2023)
1.5 Global Motion Sickness Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Motion Sickness Treatment Market Size (2018-2029)
1.6.1 North America Motion Sickness Treatment Market Size (2018-2029)
1.6.2 Europe Motion Sickness Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Motion Sickness Treatment Market Size (2018-2029)
1.6.4 Latin America Motion Sickness Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Motion Sickness Treatment Market Size (2018-2029)
2 Motion Sickness Treatment Market by Type
2.1 Introduction
2.1.1 Anticholinergic
2.1.2 Antihistamines
2.1.3 Others
2.2 Global Motion Sickness Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Motion Sickness Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Motion Sickness Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Motion Sickness Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Motion Sickness Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Motion Sickness Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Motion Sickness Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Motion Sickness Treatment Revenue Breakdown by Type (2018-2029)
3 Motion Sickness Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Motion Sickness Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Motion Sickness Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Motion Sickness Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Motion Sickness Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Motion Sickness Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Motion Sickness Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Motion Sickness Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Motion Sickness Treatment Revenue Breakdown by Application (2018-2029)
4 Motion Sickness Treatment Competition Analysis by Players
4.1 Global Motion Sickness Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Motion Sickness Treatment as of 2022)
4.3 Date of Key Players Enter into Motion Sickness Treatment Market
4.4 Global Top Players Motion Sickness Treatment Headquarters and Area Served
4.5 Key Players Motion Sickness Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Motion Sickness Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Profile
5.1.2 GlaxoSmithKline Main Business
5.1.3 GlaxoSmithKline Motion Sickness Treatment Products, Services and Solutions
5.1.4 GlaxoSmithKline Motion Sickness Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 GlaxoSmithKline Recent Developments
5.2 Perrigo Company
5.2.1 Perrigo Company Profile
5.2.2 Perrigo Company Main Business
5.2.3 Perrigo Company Motion Sickness Treatment Products, Services and Solutions
5.2.4 Perrigo Company Motion Sickness Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Perrigo Company Recent Developments
5.3 Prestige Brands
5.3.1 Prestige Brands Profile
5.3.2 Prestige Brands Main Business
5.3.3 Prestige Brands Motion Sickness Treatment Products, Services and Solutions
5.3.4 Prestige Brands Motion Sickness Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 WellSpring Pharmaceutical Corporation Recent Developments
5.4 WellSpring Pharmaceutical Corporation
5.4.1 WellSpring Pharmaceutical Corporation Profile
5.4.2 WellSpring Pharmaceutical Corporation Main Business
5.4.3 WellSpring Pharmaceutical Corporation Motion Sickness Treatment Products, Services and Solutions
5.4.4 WellSpring Pharmaceutical Corporation Motion Sickness Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 WellSpring Pharmaceutical Corporation Recent Developments
5.5 Caleb Pharmaceuticals
5.5.1 Caleb Pharmaceuticals Profile
5.5.2 Caleb Pharmaceuticals Main Business
5.5.3 Caleb Pharmaceuticals Motion Sickness Treatment Products, Services and Solutions
5.5.4 Caleb Pharmaceuticals Motion Sickness Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Caleb Pharmaceuticals Recent Developments
5.6 Myungmoon Pharm
5.6.1 Myungmoon Pharm Profile
5.6.2 Myungmoon Pharm Main Business
5.6.3 Myungmoon Pharm Motion Sickness Treatment Products, Services and Solutions
5.6.4 Myungmoon Pharm Motion Sickness Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Myungmoon Pharm Recent Developments
5.7 Baxter International
5.7.1 Baxter International Profile
5.7.2 Baxter International Main Business
5.7.3 Baxter International Motion Sickness Treatment Products, Services and Solutions
5.7.4 Baxter International Motion Sickness Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Baxter International Recent Developments
5.8 Reliefband Technologies
5.8.1 Reliefband Technologies Profile
5.8.2 Reliefband Technologies Main Business
5.8.3 Reliefband Technologies Motion Sickness Treatment Products, Services and Solutions
5.8.4 Reliefband Technologies Motion Sickness Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Reliefband Technologies Recent Developments
6 North America
6.1 North America Motion Sickness Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Motion Sickness Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Motion Sickness Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Motion Sickness Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Motion Sickness Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Motion Sickness Treatment Market Dynamics
11.1 Motion Sickness Treatment Industry Trends
11.2 Motion Sickness Treatment Market Drivers
11.3 Motion Sickness Treatment Market Challenges
11.4 Motion Sickness Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
